CY1105683T1 - Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου - Google Patents

Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου

Info

Publication number
CY1105683T1
CY1105683T1 CY20061100133T CY061100133T CY1105683T1 CY 1105683 T1 CY1105683 T1 CY 1105683T1 CY 20061100133 T CY20061100133 T CY 20061100133T CY 061100133 T CY061100133 T CY 061100133T CY 1105683 T1 CY1105683 T1 CY 1105683T1
Authority
CY
Cyprus
Prior art keywords
hydrophobic
acantho
preparation
amino acids
porcupine
Prior art date
Application number
CY20061100133T
Other languages
English (en)
Inventor
Angelika Esswein
Kurt Lang
Petra Rueger
Tilmann Seytter
Original Assignee
Curis, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Curis, Inc. filed Critical Curis, Inc.
Publication of CY1105683T1 publication Critical patent/CY1105683T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ένα ακανθοχοιρικό συζυγές το οποίο χαρακτηρίζεται από ότι περιέχει:(α) ένα πολυπεπτίδιο συντιθέμενο από 10 έως 30 υδρόφοβα αμινοξέα, ή από αμινοξέα τα οποία σχηματίζουν διαμεμβρανικούς έλικες και είναι φορτισμένα θετικά, ή(β) 1 έως 4 αλειφατικά, κορεσμένα ή ακόρεστα υδρογονανθρακικά ιζήματα με ένα μήκος αλυσίδας από 8 έως 24 ατόμων C και με μία υδρόφοβη δράση , ή(γ) μία υδρόφοβη θειική χημική ένωση, όπου ένα από τα (α) έως (γ) είναι ομοσθενικά συνδεδεμένο σε μία ακανθοχοιρική πρωτεΐνη και η οποία έχει μία πολλαπλάσια αυξημένη δραστικότητα και είναι κατάλληλη ως ένας φαρμακευτικός παράγοντας.
CY20061100133T 1998-04-30 2006-02-01 Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου CY1105683T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03
EP99108032A EP0953576B1 (en) 1998-04-30 1999-04-23 Active hedgehog protein conjugate, process for its production and use

Publications (1)

Publication Number Publication Date
CY1105683T1 true CY1105683T1 (el) 2010-12-22

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100133T CY1105683T1 (el) 1998-04-30 2006-02-01 Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου

Country Status (18)

Country Link
US (4) US6468978B1 (el)
EP (2) EP1557427A3 (el)
JP (1) JP3433136B2 (el)
KR (1) KR19990083621A (el)
CN (1) CN1233616A (el)
AT (1) ATE308563T1 (el)
AU (1) AU719797B2 (el)
CA (1) CA2269221A1 (el)
CY (1) CY1105683T1 (el)
DE (1) DE69928040T2 (el)
DK (1) DK0953576T3 (el)
ES (1) ES2252886T3 (el)
HU (1) HUP9901411A2 (el)
IL (1) IL129620A (el)
MA (1) MA26625A1 (el)
NO (1) NO992090L (el)
NZ (1) NZ335385A (el)
SG (1) SG80028A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312009A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (en) * 1998-04-30 2005-10-19 Curis, Inc. Hedgehog protein conjugate
ATE310531T1 (de) 1998-08-07 2005-12-15 Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000035948A1 (en) * 1998-12-03 2000-06-22 Biogen, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
WO2000073337A1 (en) * 1999-06-01 2000-12-07 Biogen, Inc. Polymer conjugates of hedgehog proteins and uses
WO2001082994A1 (en) * 2000-04-28 2001-11-08 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
MX351353B (es) * 2011-06-06 2017-10-11 Kineta One Llc Composiciones farmacéuticas basadas en shk y métodos para prepararlas y usarlas.
EP3024887B1 (en) 2013-07-26 2023-11-22 The Penn State Research Foundation Method for preparation of polymer compositions and coatings
EP3384935A4 (en) * 2015-12-02 2019-08-21 Hanmi Pharm. Co., Ltd. PROTEIN COMPLEX UTILIZING A FATTY ACID DERIVATIVE, AND PROCESS FOR PREPARING THE SAME

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
CA2071912C (en) * 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
WO1995018856A1 (en) * 1993-12-30 1995-07-13 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
IL129295A0 (en) * 1996-10-07 2000-02-17 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
CA2312009A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
JP4289788B2 (ja) * 1997-12-03 2009-07-01 バイオジェン・アイデック・エムエイ・インコーポレイテッド 疎水性修飾されたタンパク質組成物および産生方法
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (en) * 1998-04-30 2005-10-19 Curis, Inc. Hedgehog protein conjugate
ATE310531T1 (de) * 1998-08-07 2005-12-15 Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
WO2001082994A1 (en) * 2000-04-28 2001-11-08 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
EP1557427A2 (en) 2005-07-27
SG80028A1 (en) 2001-04-17
CN1233616A (zh) 1999-11-03
US20070191274A1 (en) 2007-08-16
JP3433136B2 (ja) 2003-08-04
IL129620A0 (en) 2000-02-29
NZ335385A (en) 2000-09-29
EP0953576B1 (en) 2005-11-02
CA2269221A1 (en) 1999-10-30
HUP9901411A2 (hu) 1999-12-28
MA26625A1 (fr) 2004-12-20
NO992090D0 (no) 1999-04-29
AU2500999A (en) 1999-11-11
US7153836B2 (en) 2006-12-26
NO992090L (no) 1999-11-01
US6818623B2 (en) 2004-11-16
ATE308563T1 (de) 2005-11-15
EP1557427A3 (en) 2005-10-19
IL129620A (en) 2009-06-15
HU9901411D0 (en) 1999-07-28
DK0953576T3 (da) 2006-03-20
EP0953576A1 (en) 1999-11-03
DE69928040D1 (de) 2005-12-08
AU719797B2 (en) 2000-05-18
US20050148510A1 (en) 2005-07-07
US20030139574A1 (en) 2003-07-24
DE69928040T2 (de) 2006-07-27
ES2252886T3 (es) 2006-05-16
KR19990083621A (ko) 1999-11-25
US6468978B1 (en) 2002-10-22
JP2000053699A (ja) 2000-02-22

Similar Documents

Publication Publication Date Title
CY1105683T1 (el) Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
AR021448A1 (es) Metodo para producir un polipeptido quimerico
ES2095852T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
DE3587579D1 (de) Pharmazeutische Zubereitung enthaltend eine Tetrahydropyrrolverbindung als aktiven Bestandteil und Verfahren zur Herstellung dieser Tetrapyrrolverbindung.
ATE204881T1 (de) Chimäre lipidkörper-pro-grf analoge mit erhöheter biologischer potenz
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
CY1110927T1 (el) Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων
DE60043620D1 (de) Mage-a1 peptide die von klasse ii hla molekule presentiert werden
ES554921A0 (es) Procedimiento para la obtencion de derivados de oligopeptido, de efecto tensioactivo compatible con la piel
ES2084150T3 (es) Aminoacidos, peptidos o sus derivados asociados a las grasas.
CY1105331T1 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
ATE89566T1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum- produzierten proteins in hepatozyten und zusammensetzungen davon.
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
ES508633A0 (es) Un procedimiento para la preparacion de nuevos conjugados de inmunoglobulina utiles como agentes anticancerosas.
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
PT87536A (pt) Process for the preparation of cyclic anticoagulant peptides
EA200401565A1 (ru) Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
ES2039402T3 (es) Empleo de peptidos n,n'-bis-l-aminoacido-l-cistina en preparados de aminoacidos para alimentacion oral y parenteral.
PT82215B (pt) Processo para a preparacao de naticorpos monoclonais contra peptidos natriureticos auriculares de seres humanos
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
FR2599036B1 (fr) Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
ATE317021T1 (de) Antisense modulierung von lfa-3